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Abstract
Background: Associations between demographic data and pulmonary function have not been adequately examined
in patients that underwent Roux-en-Y Gastric Bypass (RYGB). This study was designed to examine changes in body fat
distribution and metabolic parameters after RYGB and whether these changes correlated with improved lung function.
Methods: A retrospective review of 32 ethnic Chinese with obesity with body mass index (BMI) 28–35 kg/m2 and type
2 diabetes (T2DM) was conducted, focusing on metabolic outcomes and pulmonary function 6 months after RYGB.
Results: Forced expiratory volume during first second (FEV1), percentage of forced expiratory volume during first
second (FEV1 [%pred]), forced vital capacity (FVC), and percentage of forced vital capacity (FVC [%pred]) all improved
significantly after RYGB. These increases all were negatively correlated with decreases in body weight and visceral fat
area (VFA). The improvements of FEV1, FEV1 [%pred] and FVC were also negatively correlated with baseline of body
weight and VFA. Furthermore, increases in FEV1 and FVC were independently associated with baseline of VFA
(β = −0.003, P = 0.000; β = −0.004, P = 0.002, respectively).
Conclusions: The baseline of VFA and weight loss induced by RYGB independently correlated with improved
pulmonary function in Chinese patients.
Keywords: Body weight, Obesity, Abdominal, Visceral fat, Diabetes, Type 2, Pulmonary function test
Background
Obesity adversely affects pulmonary function, especially
in those exhibiting the restrictive pattern of functional
impairment [1–3]. Such impairment is found in patients
with impaired glucose tolerance (IGT), diabetes, metabolic
syndrome and cardiovascular disease [3–5]. However, pre-
vious work examining the association of pulmonary func-
tion with abdominal obesity defined by body weight, waist
circumference (WC), hip circumference, body mass index
(BMI), waist-to-height or waist-to-hip ratio remains con-
troversial [1, 6–9]. Studies using visceral fat area (VFA) to
more accurately measure abdominal obesity in morbidly
obese T2DM patients and examine the correlation with
pulmonary function are lacking.
Roux-en-Y gastric bypass (RYGB) is currently performed
in T2DM subjects with BMI over 35kg/m2, with evidence
from the literature that RYGB may be appropriate for
Chinese T2DM patients with BMI 25-35kg/m2 [10]. By
criteria HbA1c <6.5 %, the pencentage of patients with
diabetes remission were 61 to 93 % at 12 months after
gastric bypass [11, 12]. For example, in T2DM patients
with BMI < 35 kg/m2 who underwent RYGB, BMI de-
creased from 34.6 ± 0.8 kg/m2 to 25.8 ± 2.5 kg/m2 and
HbA1c levels decreased from 8.2 ± 2.0 % to 6.1 ± 2.7 %,
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1 year after RYGB [13]. Furthermore, the VFA: subcutane-
ous fat area (SFA), ratio fell substantially after surgical
intervention in obese patients with T2DM, suggesting that
weight loss after RYGB preferentially affects abdominal
fat, particularly visceral fat [14]. Several studies have found
that mortality during bariatric surgery is associated with
respiratory complications [15, 16]. Postoperative respira-
tory complications including tachypnea, arterial oxygen
desaturation, atelectasis, pneumonia, hypoxemia, and hy-
percapnia have all been noted [6]. Importantly, several
studies that included long-term follow-up have found that
weight loss after bariatric surgery greatly improves pul-
monary function by increasing the forced vital capacity
(FVC) [17, 18] and the forced expiratory volume in 1 s
(FEV1) [18]. However, it has been proposed that ethnic
differences exist among patients and, to date, neither
cross-sectional nor longitudinal associations between
demographic data and pulmonary function have been ad-
equately examined in Chinese patients treated with RYGB.
Moreover, no study has yet used the reduction in VFA
measured via magnetic resonance imaging (MRI), an ac-
curate assessment of abdominal obesity, to study the asso-
ciation with improvements in pulmonary function after
RYGB.
In this study, we evaluated baseline and changes in
obesity by using body weight, BMI, VFA, SFA and in
lipid metabolism. We then examined their association
with improvement of pulmonary function in Chinese
obese patients with BMI 28–35 kg/m2 and T2DM,
followed up to 6 months after RYGB.
Methods
Patients
This was a retrospective observational study approved
by the Ethics Committee of the Shanghai Jiaotong Uni-
verstity affiliated No. 6 Hospital. Between February 2011
and January 2012, 32 Chinese patients (14 males and 18
females) aged 18 to 65 years, who were obese (BMI 28–
35 kg/m2) and who had T2DM, underwent laparoscopic
RYGB (LRYGB) in our hospital and were enrolled in the
present study. All patients underwent identical anaes-
thetic and surgical protocols. All surgeries were per-
formed laparoscopically using a standardized technique.
A 25 mL gastric pouch was divided from the distal
remnant. The biliopancreatic and alimentary limbs were
100–120 cm in length. Pulmonary function (spirometry),
weight, BMI, VFA, SFA and lipid metabolism were eval-
uated in the preoperative period and 6 months after sur-
gery. Smoking history was recorded. Any patient with a
history of open abdominal surgery, a serious disease
(such as a heart or lung insufficiency) that was incom-
patible with surgery, an acute T2DM complication, severe
alcohol or drug dependency, a mental disorder, type 1
DM, secondary diabetes, an unstable psychiatric illness;
who was a relatively high surgical risk (such as a patient
with an active ulcer); or who was unable to adequately
undergo pulmonary function testing was excluded. The
written informed consent for participation in the study
was obtained from participants.
Pulmonary function tests
Evaluation of pulmonary function was carried out with
each patient in a sitting position, with nose clips in
place, via body plethysmography (Jaeger Masterscreen
Body, Würzburg, Germany). All tests were performed by
the same team of technicians, who followed the recom-
mendations of the American Thoracic Society (ATS)/
European Respiratory Society (ERS) [19]. Knudson’s ref-
erence equations were used to derive predicted values of
pulmonary function test results. Each patient repeated
each test at least three times (yielding at least two repro-
ducible and acceptable maneuvers). The FVC, FEV1, and
FEV1/FVC ratio were measured. The results were con-
sidered to be reproducible if the second-highest FVC
and FEV1 values were within 5 % of the highest values.
The highest measured FEV1 value and the correspond-
ing FVC were coded to allow for computer analysis. The
results were expressed in absolute values and as percent-
ages of predicted normal values (FEV1 [%pred] and FVC
[%pred]).
Evaluation of VFA and SFA
VFA and SFA were measured using a Philips Achieva
3.0-T MRI system (Philips Medical Systems, Eindhoven,
the Netherlands) fitted with standard array coils; all sub-
jects were in the supine position. Breath-hold FISP images
centred on the L4-L5 intervertebral disc were obtained
using standard localizer images. The following parameters
were employed: Repetition Time (TR) = 4 ms, Echo Time
(TE) = 2 ms, number of slices = 12, slice thickness = 8 mm,
image matrix 256 × 256, and field-of-view = 500 × 500 mm.
The four slices that were best-aligned with the L4-L5 disc
were analyzed with the aid of the SliceOmatic 5.0 software
package (Escape Medical Viewer V3.2) to obtain VFA and
SFA values by fitting spline curves to points on the border
of the subcutaneous and visceral regions. Non-fat areas
within the visceral region were also outlined via spline fit-
ting and subtracted from total visceral areas [20] .
Statistical analysis
All statistical analyses were performed using SPSS version
20.0 (SPSS, Chicago, IL). Data on normally distributed var-
iables were expressed as means ± standard deviations and
analysed with the aid of the Shapiro-Wilk test. Data on
skewed variables were expressed as medians (with inter-
quartile ranges). After verifying the normality of distribu-
tion, the paired t-test was used to compare preoperative
and 6-month postoperative results. Pearson correlation
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analysis was used to search for relationships among weight,
BMI, VFA, SFA, measures of lipid metabolism, FEV1,
FEV1 (%pred), FVC, FVC (%pred), and FEV1/FVC. Step-
wise multiple regression analysis was used to identify inde-
pendent parameters correlated with changes in pulmonary
function. All reported P-values are two-tailed, and P < 0.05
was considered to reflect statistical significance.
Results
Patient characteristics, including age, gender, smoking sta-
tus, BMI, weight, VFA, SFA and lipid metabolism data, be-
fore and 6 months after RYGB, are shown in Table 1. The
average reduction in VFA after RYGB was 70.9 %. This
was much greater than the average drop in SFA (44.0 %).
Significant reductions 6 months after surgery were noted
in weight, BMI, and levels of total cholesterol (TC), tri-
glycerides (TG) and low-density lipoprotein cholesterol
(LDL-c). The BMI returned to normal in 21 patients and,
in 8, fell into the range of overweight (25–28 kg/m2); only
3 patients remained obese (≥28 kg/m2) despite significant
reductions in their BMI.
FEV1, FEV1 (%pred), FVC, and FVC (%pred) increased
significantly after surgery. Although the FEV1/FVC ratio
did not change significantly, a tendency toward an in-
crease was evident (P < 0.1) (Fig. 1).
Increases in FEV1, FEV1(%pred), FVC and FVC(%pred)
were negatively correlated with baseline and decreases
in weight and VFA. Although increase in FVC(%pred)
were not significantly correlated with baseline in weight
and VFA, a possible correlation was evident (P < 0.1;
Table 2 and Fig. 2). Furthermore, significant negative cor-
relations were evident between increases in FEV1(%pred),
FVC and FVC(%pred) and decreases in BMI, and between
increases in FVC(%pred) and baseline of BMI. Increase in
FEV1 was positively correlated with increase in HDL-
c level. Significantly negative correlations were evi-
dent between increase in FEV1 (%pred) and decrease
in TG level. Changes in pulmonary function were not
significantly correlated with baseline of lipid metabol-
ism (Table 2).
Multiple stepwise regression analysis showed that
increase in FEV1 (%pred) (β = −0.730, P < 0.0001) and
FVC (%pred) (β = −0. 747, P = 0.001) were independ-
ently associated with decrease in weight, and that in-
creases in FEV1 and FVC were independently associated
with baseline of VFA (β = −0.003, P = 0.000; β = −0.004,
P = 0.002, respectively), after adjustment for confound-
ing factors. In addition, age was an independent risk
factor for increase in FEV1 (%pred), and increase of
HDL-c was an independent risk factor for increase in
FEV1 (Table 3).
Discussion
To the best of our knowledge, this is the first study to
address the relationship between VFA and pulmonary
function in obese T2DM Chinese patients. We observed
that six months after RYGB surgery, significant reduc-
tions in BMI, body weight, VFA, SFA and TC, TG, LDL-
c were evident, and HDL-c levels were significantly
higher. Lung function improved markedly, based on
FEV1, FEV1 (%pred), FVC, and FVC (%pred) values.
This is in keeping with previous work which found that
FVC and the FEV1/FVC ratio recovered in morbidly
obese females 6 months after surgery, and that FEV1 re-
covered by 1 year [21]. Though the improvement was
not so evident, it had significance. Because respiratory
failure(blood gas analysis suggests type I or type II re-
spiratory failure) was a contraindication for surgery,
Table 1 Demographic data, VFA, SFA and lipid metabolism of obesity and T2DM before and 6 months after RYGB
Variables Before RYGB(V1) After RYGB Δ P
n 32 — — —
Male/Female 14/18 — — —
Age (years) 45.09 ± 11.26 — — —
Smoker 7 (21.9 %) — — —
Weight (kg) 84.2 ± 14.4 66.8 ± 11.0 17.5 ± 6.2 <0.0001
BMI (kg/m2) 30.7 ± 3.5 24.4 ± 2.4 6.37 ± 2.2 <0.0001
VFA (cm2) 123.5 ± 36.4 40.1 ± 25.0 87.6 ± 36.3 <0.0001
SFA (cm2) 278.9 ± 82.7 163.2 ± 71.9 122.8 ± 59.9 <0.0001
TC (mmol/L) 5.03 ± 1.07 4.27 ± 1.16 0.81 ± 0.91 <0.0001
TG (mmol/L) 1.69 (1.37 ~ 2.80) 0.98 (0.84 ~ 1.50) 0.74 (0.48 ~ 1.14) <0.0001
HDL-c (mmol/L) 1.06 ± 0.25 1.17 ± 0.23 −0.14 ± 0.19 <0.0001
LDL-c (mmol/L) 2.86 ± 0.85 2.41 ± 0.88 0.55 ± 0.86 <0.0001
Data are mean ± SD or median (interquartile range). BMI: Body mass index, VFA: visceral fat area, SFA: subcutaneous fat area, TC: total cholesterol; TG: triglyceride;
HDL-c: high density lipoprotein cholesterol; LDL-c: low density lipoprotein cholesterol
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we enrolled patients with mild or moderate abnormal
lung function, without apparent symptoms of dyspnea.
We believed that studying a population with a higher
BMI may suggest more benefit, especially if they were
symptomatic. Considering the risks of anesthesia, we
cannot yet enroll patients with apparent breathing
difficulties.
Additional studies [6–8] have found that respiratory
function improved with weight loss or waist-to-hip ra-
tio, in morbidly obese patients 1 year after bariatric
surgery. Paradoxically, waist-to-hip ratio did not sig-
nificantly correlate with FVC and FEV1 after bariatric
surgery in a Chinese population, although body weight,
BMI, WC, hip circumference, and waist-to-height ratio
did correlate well with FVC and FEV1 [1]. One study
has observed that respiratory drive was reduced after
weight loss induced by bariatric surgery [9]. In the
present study, 6 months after surgery, we observed
increases in FEV1, FEV1 (%pred) and FVC and clearly
established that these were correlated with weight
loss and baseline of weight. Others have reported
similar results in populations varying in terms of eth-
nicity [1, 6–8].
Most importantly, we established for the first time that
baseline and decreases in VFA was correlated with in-
creases in FEV1, FEV1 (%pred) and FVC. In particular,
Fig. 1 Pulmonary results of obesity and type 2 diabetes before and 6 months after RYGB. FEV1:forced expiratory volume during first second.
FEV1(%pred): percentage of forced expiratory volume during first second. FVC: forced vital capacity. FVC(%pred): percentage of forced vital capacity.
FEV1/FVC, %: percentage of ratio of forced expiratory volume in 1 s to forced vital capacity. Increase in a FEV1 and FVC. b FEV1(%pred), FVC(%pred) and
FEV1/FVC. A paired t-test have been used here for statistical analysis
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baseline of VFA was independently and significantly re-
lated to increases in FEV1 and FVC. A reduction in the
VFA may have improved respiratory mechanics, conse-
quently increasing FEV1, FEV1 (%pred), and FVC, as
shown by the significant correlations among these vari-
ables (Fig. 2). In several former studies, simple mea-
surements of abdominal obesity such as WC, the waist-
to-hip ratio, or the waist-to-height ratio were found to
be correlated with respiratory function [1, 6–8]. Fur-
thermore, an increasing number of studies suggests
that WC may be a better predictor of pulmonary func-
tional impairment than other anthropometric obesity
indices [1, 2, 4]. In the present study, the average re-
duction in VFA after RYGB far exceeded that of SFA,
and was associated with improved respiratory function
6 months later. By accurately measuring the extent of
visceral fat via MRI in the present study, we have
clearly confirmed that obesity, especially abdominal
obesity, affects pulmonary function. We believe that
direct measurement of VFA using MRI affords a more
accurate assessment of obesity than does WC or calcu-
lation of waist-to-hip ratios. We appreciate that MRI
use is impractical in large-scale observational studies,
however there is no doubt that it confers more accur-
acy and diagnostic power when applied to correlating
obesity with related complications.
Obesity may influence pulmonary function because ex-
cess fat accumulation in the abdominal cavity and on
the chest wall affects chest mechanics, increasing the
work of breathing, reducing lung volumes, rendering re-
spiratory muscles dysfunctional, impairing gas exchange
and reducing exercise tolerance [7, 17, 22–26]. Our re-
sults may be attributable to upward physical pressure on
the diaphragm caused by the increased abdominal vol-
ume of obese individuals. There has also been great
interest in understanding the role of altered lipid metab-
olism in contributing to altered pulmonary function after
weight loss. In keeping with a previous study, [27] we
found no association between LDL-c levels and pulmon-
ary function. Moreover, we found that only HDL-c levels
were independently positively correlated with FEV1 and
this may reflect the role played by HDL-c in immuno-
regulation and attenuation of inflammation [28].
The present study has several limitations, including a
small sample size and a limited follow-up duration, how-
ever the current data and conclusions provide important
verification on the predictive accuracy of VFA measures.
Although the small number of patients imposed limita-
tions on analyses, we regressed our data to explore
whether immediate postoperative respiratory functions
were associated with gender, age, BMI, lipid metabolism,
weight or VFA. In general, weight and VFA, but not
Table 2 Anthropometric and biochemical parameters showing significant correlations with changes in FEV1, FEV1(%pred), FVC, FVC
(%pred)
ΔFEV1 ΔFEV1 (%pred) ΔFVC ΔFVC (%pred)
Univariatea Univariatea Univariatea Univariatea
r P r P r P r P
ΔWeight (kg) −0.493** 0.005 −0.620** <0.0001 −0.522** 0.003 −0.574** 0.001
ΔBMI (kg/m2) −0.354 0.051 −0.528** 0.002 −0.440* 0.013 −0.533** 0.002
ΔVFA (cm2) −0.632** <0.0001 −0.435* 0.015 −0.537** 0.002 −0.331 0.069
ΔSFA (cm2) −0.039 0.836 −0.184 0.321 −0.046 0.808 −0.156 0.401
ΔTC (mmol/L) 0.217 0.242 0.115 0.539 0.058 0.757 −0.003 0.987
ΔTG (mmol/L) −0.328 0.071 −0.208 0.261 −0.364* 0.044 −0.243 0.188
ΔHDL-c (mmol/L) 0.362* 0.045 0.116 0.535 0.069 0.711 0.123 0.510
ΔLDL-c (mmol/L) 0.306 0.094 0.165 0.374 0.236 0.202 −0.120 0.513
Weight (kg) V1 −0.462** 0.008 −0.398* 0.024 −0.381* 0.031 −0.320 0.074
BMI (kg/m2) V1 −0.280 0.121 −0.343 0.054 −0.333 0.062 −0.370* 0.037
VFA (cm2) V1 −0.642** 0.000 −0.439* 0.012 −0.534** 0.002 −0.336 0.060
SFA (cm2) V1 0.041 0.823 −0.029 0.876 0.021 0.909 −0.051 0.781
TC (mmol/L) V1 0.138 0.450 0.062 0.736 0.170 0.353 0.098 0.593
TG (mmol/L) V1 −0.191 0.295 −0.094 0.609 −0.183 0.315 −0.111 0.546
HDL-c (mmol/L) V1 0.342 0.055 0.096 0.601 0.278 0.124 0.067 0.717
LDL-c (mmol/L) V1 0.224 0.217 0.132 0.471 0.245 0.176 0.165 0.366
*P < 0.05, **P < 0.01
aPearson’s correlation analyses were performed
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SFA, influenced the rate of postoperative respiratory im-
provement. Another limitation is the lack of the control
arm and hence it is not clear whether the findings are
due to surgery itself or just the weight loss.
Conclusions
We found that VFA decreased significantly 6 months
after LRYGB. Decrease of VFA and weight loss after bar-
iatric surgery were correlated to improved respiratory
performance, as evidenced by the increases in lung vol-
umes (FEV1, FEV1 [%pred], FVC, and FVC [%pred]) of
obese Chinese patients with T2DM. The improvements
in pulmonary function 6 months after LRYGB were in-
dependently associated with the extent of weight loss
and, in particular, baseline of VFA. We propose that pa-
tients who have more visceral fat may obtain greater
benefit from RYGB surgery than those with less visceral
fat. However, further studies with higher sample size and
Fig. 2 Correlations between the changes in weight and VFA and changes in FEV1, FEV1(%pred), FVC and FVC(%pred). Correlation of changes in
a weight and FEV1. b VFA and FEV1. c weight and FVC. d VFA and FVC. e weight and FEV1(%pred). f VFA and FEV1(%pred). g weight and
FVC(%pred). h VFA and FVC(%pred)
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long-term follow-up are needed to more conclusively es-
tablish the link between VFA and pulmonary functional
improvement.
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